Global Long Acting Injectable Anti-psychotic Market: Size, Trends & Forecasts (2017-2021) April 2017
Global Long Acting Injectable Anti-psychotic Market Report Scope of the Report The report entitled Global Long Acting Injectable Anti-psychotic Market: Size, Trends & Forecasts (2017-2021), provides analysis of the global long acting injectable anti-psychotic market, with detailed analysis of market size and growth, and segmentation of the industry. The analysis includes the market by value and by segmentation. The report also includes a detailed regional analysis of the long acting injectable anti-psychotic market in the region of the US. Under competitive landscape, different products in the long acting injectable anti-psychotic market have been compared on the basis of different parameters such as dosing frequency, patent expiry, injection sites, label, storage, needles and available strengths. Also, a financial comparison of long acting injectable market players in the US has been done. Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global long acting injectable anti-psychotic market has also been forecasted for the years 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Johnson & Johnson, Eli Lily and Company, Alkermes Public Limited Company and Lundbeck are some of the key players operating in the global long acting injectable anti-psychotic market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided. Country Coverage The US Company Coverage Johnson & Johnson Eli Lily and Company Alkermes Public Limited Company Lundbeck
Global Long Acting Injectable Anti-psychotic Market Report Executive Summary Anti-psychotic refers to a class of medicine used for the treatment of psychosis and various other emotional and mental conditions. Psychosis consist of delusions, hallucinations, paranoia and disordered thought. It is a condition in which a person experiences thought disorder and personality changes. Long acting injectable anti-psychotics are a sub type of antipsychotics which were primarily developed to improve the treatment of schizophrenia. The global long acting injectable anti-psychotic market can be studied on the basis of different products and on the basis of prescription. These products are different types of long acting injectable anti-psychotic namely Invega Sustenna/ Trinza, Risperdal Consta, Abilify Maintena, Zyprexa, Aristada and many more. The global long acting injectable anti-psychotic market is expected to increase at a healthy rate during the forecast period (2017-2021). The global long acting injectable anti-psychotic market is supported by various growth drivers, such as increasing cases of schizophrenia, rising number of bipolar disorder patients and non adherence to oral anti-psychotic. However, side effect associated with anti-psychotic and patent expiry of some of the leading brands are some of the challenges faced by the market. Aging dernography, grant of approval to Trevicta in European Commission, third party proprietary technologies and label expansion of Abilify Maintena are some of the latest trends in the global long acting injectable anti-psychotic market
Global Anti-psychotic Market Overview Figure: Global Anti-psychotic Market by Value; 2011-2016 () Figure: Global Anti-psychotic Market by Volume; 2017-2021 (Million Units) 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 The global anti- psychotic market declined to US$ billion in 2016 in comparison to a value of US$ billion in 2015. It is expected that the anti- psychotic market would reach to a value of billion by 2021 growing at a CAGR of % over the years 2017-2021.
Global Long Acting Injectable Anti-psychotic Market Overview Figure : Global Long Acting Injectable Antipsychotic Market by Value; 2015-2021 () Figure : Global Long Acting Injectable Anti-psychotic Market Value by Product; 2016 2015 2016 2017 2018 2019 2020 2021 Figure 8: Global Long Acting Injectable Anti-psychotic Market Volume by Products; 2016 The global long acting injectable antipsychotic market reached US$... billion in 2015. It is projected that the market would be amounting to US$... billion by 2021 in comparison to a value of US$... billion in 2016 exhibiting a CAGR of % over the years 2017-2021. Invega Sustenna evolved as the leading product in the market with a share of % amounting to billion.
Global Long Acting Injectable Anti- psychotic Market: Regional Overview Figure: Global Long Acting Injectable Anti-psychotic Market by Region; 2016 Figure: The US Long Acting Injectable Anti-psychotic Market by Value 2016-2021 () 2016 2017 2018 2019 2020 2021 The global long acting injectable anti- psychotic market consist of regions of US and rest of the world. US accounted for a share of % in the overall market and totaled to US$... Billion. The US long acting injectable anti- psychotic market valued to billion in 2016. It is further anticipated that the market would reach to a value of billion by 2021 exhibiting a CAGR of % during the years 2017-2021.